Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. root
  2. QUTENZA (capsaïcine)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

QUTENZA (capsaïcine)

Medicine - Posted on Apr 12 2018 - Updated on Jun 12 2019
Active substance (DCI)
  • capsaïcine
history (3)
  • 2/21/18

    QUTENZA (capsaicin), local analgesic patch

    Insufficient actual benefit to justify its inclusion on the list of reimbursable products for peripheral neuropathic pain in...
    icône flèche
  • 10/5/16

    QUTENZA (capsaicin), local analgesic patch

    No clinical benefit demonstrated in peripheral neuropathy pain QUTENZA is a transdermal system with Marketing Authorisation ...
    CAV :
    54321
    icône flèche
  • 12/15/10

    QUTENZA

    Pas d’avantage clinique démontré dans les douleurs neuropathiques périphériques QUTENZA est indiqué pour le traitement des d...
    CAV :
    54321
    icône flèche
Technical information
ATC code
  • N01BX04
Manufacturer
GRUNENTHAL
Presentation

QUTENZA 179 mg, patch cutané (code CIS : 66525842)
1 sachet(s) aluminium papier avec nécessaire(s) - Code CIP : 34009 576 838 4 9
2 sachet(s) aluminium papier avec nécessaire(s) - Code CIP : 34009 576 839 0 0

All our publications
    Diabetes mellitus Drug therapy Pain - Inflammation

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
WMuzjDKGg26Zta1Z